Psychometric evaluation of the Amphetamine Cessation Symptom Assessment

McGregor, Catherine; Srisurapanont, Manit; Mitchell, Amanda; Longo, Marie C.; Cahill, Sharon; White, Jason M.

doi:10.1016/j.jsat.2007.05.007

Cited by 47Substance Abuse Treatment and OutcomesOpioid Use Disorder TreatmentPsychometric Methodologies and Testing

Psychometric evaluation of the Amphetamine Cessation Symptom Assessment

McGregor, Catherine, Srisurapanont, Manit, Mitchell, Amanda, Longo, Marie C., Cahill, Sharon, White, Jason M.·2008·Journal of Substance Abuse Treatment

DOI 10.1016/j.jsat.2007.05.007

Open this paper in CoChat — free account

Abstract

Testing of a new scale, the Amphetamine Cessation Symptom Assessment (ACSA), in a sample of treatment-seeking amphetamine users (N = 133) showed satisfactory reliability, while factor analysis identified three components explaining 64.7% of the variance in scores. Scores were inversely related to subjective general well-being (r = -.33, p < .01) and directly related to the Beck Depression Inventory (r = .59, p < .01). There were positive relationships between the ACSA and measures of amphetamine dependence (r = .36, p < .01) and the intensity of recent amphetamine use (r = .24, p < .01). The ACSA discriminated between "low-dose" and "high-dose" users, indicating discriminant validity. In inpatients (n = 63), ACSA scores declined significantly over time, while higher scores in inpatient treatment dropouts indicated predictive validity. The ACSA showed satisfactory reliability and validity, with a three-factor solution providing the best fit to the data. The ACSA could play an important role in providing clinical outcome data, particularly in outcome evaluation of new treatment protocols.

Integrity signals

Registry

Crossref · 10.1016/j.jsat.2007.05.007

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The ACSA is a self-completed questionnaire with 16 items rated on 5-point scales (0-4), total score 0-64.
“The ACSA, a self-completed questionnaire, contains 16 items rated on 5-point scales (0 [not at all] to 4 [extremely]); total score ranges from 0–64 (McGregor et al, 2008).”
From Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials (2016) · cites this paper as McGregor et al, 2008
The Amphetamine Cessation Symptom Assessment is a validated self-report with 16 items.
“The Amphetamine Cessation Symptom Assessment (ACSA; measured at baseline and weeks 10-11 (single-blind stage)) is a validated self-report with 16 items rated from 0 (not at all) to 4 (extremely) (McGregor et al, 2008).”
From Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder (2014) · cites this paper as McGregor et al, 2008

Using multivariate statistics
Tabachnick, B. G., & Fidell, L. S. (1983) · Cited by 79,888 · see citing works
Untitled work
(1976) · Medical Entomology and Zoology · Cited by 8,899 · see citing works
An Easy Guide to Factor Analysis
Kline, P. (2014) · Routledge eBooks · doi:10.4324/9781315788135 · Cited by 3,328 · see citing works
Handbook of Psychopharmacology
Iversen, L. L., Iversen, S. D., & Snyder, S. H. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,755 · see citing works
Validating Instruments in MIS Research1
Straub, D. W. (1989) · MIS Quarterly · doi:10.2307/248922 · Cited by 2,549 · see citing works
Biostatistics : The Bare Essentials
Norman, G. R., & Streiner, D. L. (1993) · Cited by 1,498 · see citing works
The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users
Gossop, M., Darke, S. G., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995) · Addiction · doi:10.1046/j.1360-0443.1995.9056072.x · Cited by 1,341 · see citing works
Two New Rating Scales for Opiate Withdrawal
Handelsman, L., Cochrane, K. J., Aronson, M. J., Ness, R. C., Rubinstein, K. J., & Kanof, P. D. (1987) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998709001515 · Cited by 599 · see citing works
The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users
Gossop, M., Darke, S. G., Griffiths, P., et al. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb02199.x · Cited by 500 · see citing works
The nature, time course and severity of methamphetamine withdrawal
McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, S., Wongtan, T., & White, J. M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01160.x · Cited by 458 · see citing works
Self-citation
Methodological considerations in the refinement of clinical assessment instruments.
Smith, G. T., & McCarthy, D. M. (1995) · Psychological Assessment · doi:10.1037/1040-3590.7.3.300 · Cited by 311 · see citing works
Reliability and validity of the cocaine selective severity assessment
Kampman, K. M., Volpicelli, J. R., Mcginnis, D. E., Alterman, A. I., Weinrieb, R. M., D’Angelo, L., & Epperson, L. E. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00011-2 · Cited by 272 · see citing works
Methamphetamine Abstinence Syndrome: Preliminary Findings
Newton, T. F., Kalechstein, A. D., Duran, S., Vansluis, N., & Ling, W. W. (2004) · American Journal on Addictions · doi:10.1080/10550490490459915 · Cited by 216 · see citing works
Will the Methamphetamine Problem Go Away?
Rawson, R. A., Anglin, M. D., & Ling, W. W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_02 · Cited by 193 · see citing works
Amphetamine Withdrawal: I. Reliability, Validity and Factor Structure of a Measure
Srisurapanont, M., Jarusuraisin, N., & Jittiwutikan, J. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.1999.00517.x · Cited by 124 · see citing works
Self-citation
Abuse of Methylamphetamine
Hawks, D., Mitcheson, M. C., Ogborne, A. C., & Edwards, G. (1969) · BMJ · doi:10.1136/bmj.2.5659.715 · Cited by 122 · see citing works
Clinical Implications for Four Drugs of the DSM-IV Distinction Between Substance Dependence With and Without a Physiological Component
Schuckit, M. A., Daeppen, J., Danko, G. P., Tripp, M. L., Smith, T. L., Li, T. K., HESSELBROCK, V. M., & Bucholz, K. K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.41 · Cited by 82 · see citing works
ORAL USE OF STIMULANTS OBTAINED FROM INHALERS
Monroe, R. R. (1947) · JAMA · doi:10.1001/jama.1947.02890140029007 · Cited by 67 · see citing works
Central Nervous System Stimulants: Historical Aspects and Clinical Effects
ANGRIST, B. M., & Sudilovsky, A. (1978) · Springer eBooks · doi:10.1007/978-1-4757-0510-2_3 · Cited by 56 · see citing works
Self detoxication by amphetamine dependent patients: a pilot study
Cantwell, B., & McBride, A. J. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00160-9 · Cited by 51 · see citing works
Models of intervention and care for psychostimulant users
Baker, A., Lee, N., & Jenner, L. (2004) · Cited by 42 · see citing works
Asia grapples with spreading amphetamine abuse
Ahmad, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13548-9 · Cited by 38 · see citing works
The applicability of the dependence syndrome to amphetamine
Topp, L., & Darke, S. G. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00111-7 · Cited by 29 · see citing works
Handbook of Psychopharmacology, Vol. 11: Stimulants
Greaves, D. C. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.7.1003-a · Cited by 17 · see citing works

Flagged first, then by citations

Sorted by citations

A review of the clinical pharmacology of methamphetamine.
Cruickshank, C., & Dyer, K. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 747 · see citing works
Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials
McElroy, S. L., Hudson, J., Ferreira-Cornwell, M. C., Radewonuk, J., Whitaker, T., & Gasior, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.275 · Cited by 254 · see citing works
Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
Malhotra, A., Shapiro, C. M., Pépin, J., Hedner, J., Ahmed, M., Foldvary‐Schaefer, N., Strollo, P. J., Mayer, G., Sarmiento, K. F., Baladi, M. G., et al. (2019) · SLEEP · doi:10.1093/sleep/zsz220 · Cited by 250 · see citing works
Withdrawal symptoms in abstinent methamphetamine‐dependent subjects
Zorick, T. S., Nestor, L. J., Miotto, K. A., Sugar, C. A., Hellemann, G., Scanlon, G. C., Rawson, R. A., & London, E. D. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03066.x · Cited by 231 · see citing works
Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial
Hudson, J. I., McElroy, S. L., Ferreira-Cornwell, M. C., Radewonuk, J., & Gasior, M. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1889 · Cited by 158 · see citing works
Treatment for amphetamine withdrawal
Shoptaw, S. J., Kao, U., Heinzerling, K., & Ling, W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003021.pub2 · Cited by 120 · see citing works
Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual
McGregor, C., Srisurapanont, M., Mitchell, A., Wickes, W., & White, J. M. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.12.003 · Cited by 82 · see citing works
Self-citation
Addiction Research Methods
(2010) · Wiley eBooks · doi:10.1002/9781444318852 · Cited by 76 · see citing works
Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder
Madhoo, M., Keefe, R. S., Roth, R. M., Sambunaris, A., Wu, J., Trivedi, M. H., Anderson, C. S., & Lasser, R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.334 · Cited by 74 · see citing works
A placebo‐controlled trial of mirtazapine for the management of methamphetamine withdrawal
CRUICKSHANK, C. C., MONTEBELLO, M. E., DYER, K. R., QUIGLEY, A., BLASZCZYK, J., TOMKINS, S., & SHAND, D. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801935672 · Cited by 74 · see citing works
Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use
Heinzerling, K. G., Swanson, A., Hall, T. M., Yi, Y., Wu, Y., & Shoptaw, S. J. (2014) · Addiction · doi:10.1111/add.12636 · Cited by 64 · see citing works
Adjunctive Lisdexamfetamine Dimesylate Therapy in Adult Outpatients With Predominant Negative Symptoms of Schizophrenia: Open-Label and Randomized-Withdrawal Phases
Lasser, R. A., Dirks, B., Nasrallah, H. A., Kirsch, C., Gao, J., Pucci, M. L., Knesevich, M. A., & Lindenmayer, J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.111 · Cited by 46 · see citing works
Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials
Acheson, L. S., Williams, B. H., Farrell, M., McKetin, R., Ezard, N., & Siefried, K. J. (2022) · Drug and Alcohol Review · doi:10.1111/dar.13511 · Cited by 45 · see citing works
Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness
Dean, A. C., Morales, A. M., Hellemann, G., & London, E. D. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0065-1 · Cited by 39 · see citing works
A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: Feasibility, tolerability and clinical outcomes
Lee, N., Pennay, A. E., Hester, R., McKetin, R., Nielsen, S., & Ferris, J. (2012) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2012.00473.x · Cited by 35 · see citing works
Putting the call out for more research: The poor evidence base for treating methamphetamine withdrawal
Pennay, A. E., & Lee, N. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00240.x · Cited by 33 · see citing works
A Study of Abrupt Phentermine Cessation in Patients in a Weight Management Program
Hendricks, E. J., & Greenway, F. L. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181d070d7 · Cited by 32 · see citing works
Evidence-Based Assessment of Substance Use Disorder
Boness, C. L., González, J. C., Sleep, C. E., Venner, K. L., & Witkiewitz, K. A. (2023) · Assessment · doi:10.1177/10731911231177252 · Cited by 30 · see citing works
A systematic review of brief, freely accessible, and valid self-report measures for substance use disorders and treatment
Stewart, R. E., Cardamone, N. C., Schachter, A., Becker, C., McKay, J. R., & Becker‐Haimes, E. M. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109729 · Cited by 24 · see citing works
Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence
KAY‐LAMBKIN, F. J. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801914768 · Cited by 24 · see citing works
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies
Richards, C., McIntyre, R. S., Weisler, R., Sambunaris, A., Brawman-Mintzer, O., Gao, J., Geibel, B., Dauphin, M., & Madhoo, M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.07.006 · Cited by 20 · see citing works
Correlates of methamphetamine use severity among patients receiving methadone maintenance treatment for opioid use disorder in Vietnam
Giang, L. M., Li, M. J., Okafor, C. N., Diep, N. B., & Shoptaw, S. J. (2022) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108461 · Cited by 19 · see citing works
An adaptive design to screen, treat, and retain people with opioid use disorders who use methamphetamine in methadone clinics (STAR-OM): study protocol of a clinical trial
Giang, L. M., Trang, N. T., Diệp, N. B., Thuy, D. T. D., Thuy, D. T., Hòe, H. Đ., Vân, H. T. H., Thai, T. T., Nguyen, H. H., Lai, N. L., et al. (2022) · Trials · doi:10.1186/s13063-022-06278-w · Cited by 13 · see citing works
Management of withdrawal from alcohol and other drugs
Lintzeris, N., Sunjic, S., Demirkol, A., Branezac, M., Ezard, N., Siefried, K. J., Acheson, L. S., Bascombe, F., Tremonti, C., & Haber, P. (2019) · doi:10.57022/mjjp9930 · Cited by 9 · see citing works
Factors Associated with Psychotic and Depressive Symptoms in Methamphetamine Users
Karabulut, S. (2023) · Iranian Journal of Psychiatry · doi:10.18502/ijps.v19i1.14334 · Cited by 7 · see citing works
Craving self‐reports as outcome measures in drug addiction trials: A systematic review of ClinicalTrials.gov
Toulami, M., Ghasemi, K., Rafei, P., Sangchooli, A., Nafissi, N., Zonoozi, A. K., Ardabili, H. M., Ebrahimi, M., Rezapour, T., & Ekhtiari, H. (2025) · Addiction · doi:10.1111/add.70064 · Cited by 7 · see citing works
Psychometric properties of the Spanish version of the Cocaine Selective Severity Assessment to evaluate cocaine withdrawal in treatment-seeking individuals
Cobos, J. P. D. L., Trujols, J., Siñol, N., Rego, L. V. E., Castillo, I. I., & Batlle, F. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.05.004 · Cited by 4 · see citing works
Investigating the Trend and Severity of Withdrawal Symptoms in Methamphetamine Users Amongst Homeless Addicts
Khani, Y., Barati, H., Mollajan, A., Faghihi, M. M., & Rimaz, S. (2018) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.66880 · Cited by 4 · see citing works
Overcoming methamphetamine withdrawal syndrome through cognitive behavioural therapy in female correctional inmates
Fitri, K. M., & Widyastuti, R. H. (2021) · Media Keperawatan Indonesia · doi:10.26714/mki.4.4.2021.323-329 · Cited by 3 · see citing works
Exploring Nicotine Dependence Among People Using Methamphetamine During Methadone Maintenance Treatment in Vietnam
Giang, N. T., Diệp, N. B., Trang, N. T., Luan, P. T., Vân, H. T. H., Dung, D. V., Li, M. J., Lin, C., Li, L., SHOPTAW, S. J., et al. (2025) · Substance Use Research and Treatment · doi:10.1177/29768357251347819 · Cited by 2 · see citing works
Psychometric properties of the Turkish version of the Amphetamine Withdrawal Questionnaire Version 2 in patients with methamphetamine use
Karabulut, S. (2024) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.14744/dajpns.2024.00234 · Cited by 1 · see citing works
The Management of Withdrawal From Alcohol and Other Drugs in Australian Custodial Settings: A Consensus Statement
FitzGerald, G., Chan, J., Cook, J., Stoove, P. M., Curtis, M., Nielsen, S., Winter, R., & Naren, T. (2026) · The Medical Journal of Australia · doi:10.5694/mja2.70225 · Cited by 1 · see citing works
A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
Richards, C., Iosifescu, D. V., Mago, R., Sarkis, E. H., Geibel, B., Dauphin, M., McIntyre, R. S., Weisler, R. H., Brawman‐Mintzer, O., Gu, J., et al. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000897 · Cited by 1 · see citing works
Substance Use Disorders
Kane, L. F., Paquette, C. E., & Daughters, S. B. (2025) · Springer eBooks · doi:10.1007/978-1-0716-4362-4_15 · Cited by 1 · see citing works
Reliability and Validity of the Persian Version of Amphetamine Cessation Symptom Assessment (ACSA) Questionnaire in Iran
Khani, Y., Nedjat, S., Faghihi, M. M., Mollajan, A., & Rimaz, S. (2017) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.60999 · Cited by 1 · see citing works
Psychopharmacology
White, J. M., & Lintzeris, N. (2010) · doi:10.1002/9781444318852.ch14 · Cited by 1 · see citing works
Self-citation
Predictors of Psychotic and Depressive Symptoms in Metamphetamine UsersPreprint
Karabulut, S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4068671 · Cited by 1 · see citing works
Methamphetamine withdrawal: clinical profile, assessment and treatment
Cruickshank, C. (2010) · UWA Profiles and Research Repository (UWA)
Current World Literature
(2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32832ae253
Electro-acupuncture for protracted amphetamine abstinence syndrome: study protocol for a pragmatic randomized controlled trial
Ren, H., Zeng, Y., Zhang, M., Zhang, S., Chen, Z., Wu, B., Liu, J., & Ren, Y. (2022) · Trials · doi:10.1186/s13063-022-06154-7
Acupuncture for protracted amphetamine abstinence syndrome: study protocol for a systematic review and meta-analysis
Zhang, S., Luo, J., Zeng, Y., Ren, H., Chen, Z., & Ren, Y. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-062491
Pharmacologic Augmentation of Computerized Auditory Training in Chronic Psychosis: Preliminary Findings From a Single-Site, Double-Blind Study
Swerdlow, N. R., Sprock, J., Li, F., Din, J. M., Minhas, J., Talledo, J., Joshi, Y. B., Molina, J. L., Nordberg, B. A., Ing, K., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf015
Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks
Mehtani, N. J., Anderson, B. T., Alexander, I., Hendricks, P. S., Mitchell, J., Coffin, P. O., & Johnson, M. O. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-100775
Methylphenidate (D, L)
Strawn, J. R., & Stahl, S. M. (2026) · doi:10.1017/9781009642187.044
Amphetamine (D, L)
Strawn, J. R., & Stahl, S. M. (2026) · doi:10.1017/9781009642187.004
HIV Treatment Outcomes Among Methamphetamine-Using Patients on Methadone Maintenance Treatment in Vietnam: A Brief Report
Nguyen, H. N., Nguyen, D. B., Trang, N. T., (14993), L. L., Li, M. J., SHOPTAW, S. J., & Le, G. M. (2026) · AIDS and Behavior · doi:10.1007/s10461-026-05195-2
Effect of transcranial alternating current stimulation (NET Device™) on psychostimulant withdrawal severity and time course: a real-world data analysis
Greenwald, M. K., Grasser, L. R., & Winston, J. R. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1899599

Reliability and Validity of the Persian Version of Amphetamine Cessation Symptom Assessment (ACSA) Questionnaire in Iran
Khani, Y., Nedjat, S., Faghihi, M. M., Mollajan, A., & Rimaz, S. (2017) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.60999 · Cited by 1 · see citing works
Amphetamine Cessation Symptom Assessment (ACSA):: Description, strengths and knowledge gaps.
Fischer, G., ROCHE, A. M., & Duraisingam, V. (2021)
Reliability and validity of the cocaine selective severity assessment
Kampman, K. M., Volpicelli, J. R., Mcginnis, D. E., Alterman, A. I., Weinrieb, R. M., D’Angelo, L., & Epperson, L. E. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00011-2 · Cited by 272 · see citing works
Amphetamine withdrawal : nature, time course and treatment.
McGregor, C. (2005) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 3 · see citing works
Self-citation
Amphetamine Withdrawal: I. Reliability, Validity and Factor Structure of a Measure
Srisurapanont, M., Jarusuraisin, N., & Jittiwutikan, J. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.1999.00517.x · Cited by 124 · see citing works
Self-citation

Authors: McGregor, C., Srisurapanont, M., Mitchell, A., Longo, M. C., Cahill, S., & White, J. M.
Affiliations: Government of Western Australia Department of Health (AU)
Chiang Mai University (TH)
The University of Adelaide (AU)
ORCID: Srisurapanont, Manit
Cahill, Sharon
White, Jason M.
Venue: Journal of Substance Abuse Treatment
Publisher: Elsevier BV
Published: 2008-06
Volume: 34
Issue: 4
Pages: 443-449
ISSN: 0740-5472 (ISSN-L)
DOI: 10.1016/j.jsat.2007.05.007
OpenAlex: W2107194409
Cited by: 47
References: 23
Citations by year: 2026: 5 · 2025: 5 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 2 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 1
FWCI: 2.75
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Journal of Substance Abuse Treatment (publishedVersion)
PubMed (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Funders: Government of South Australia
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Keywords: amphetamine dependence, withdrawal symptoms, scale validation, psychometric properties, depression, well-being, treatment discontinuation, inpatient care, treatment outcome assessment
MeSH terms: Adult, Amphetamine, Factor Analysis, Statistical, Female, Humans, Male, Psychometrics, Surveys and Questionnaires, Reproducibility of Results, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Psychometric evaluation of the Amphetamine Cessation Symptom Assessment

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks